{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T02:35:17Z","timestamp":1740105317605,"version":"3.37.3"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"The National High Technology Research and Development Program of China","award":["2013AA032201"],"award-info":[{"award-number":["2013AA032201"]}]},{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31171308","81172208","81472610","81370842"],"award-info":[{"award-number":["31171308","81172208","81472610","81370842"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"The National Basic Research Program","doi-asserted-by":"crossref","award":["2011CB510106"],"award-info":[{"award-number":["2011CB510106"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.bbrc.2018.06.010","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T22:55:30Z","timestamp":1529103330000},"page":"249-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Combination therapy with BH3 mimetic and hyperthermia tends to be more effective on anti-melanoma treatment"],"prefix":"10.1016","volume":"503","author":[{"given":"Zhen","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baowei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganggang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4926-6996","authenticated-orcid":false,"given":"Fang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.06.010_bib1","doi-asserted-by":"crossref","first-page":"446e","DOI":"10.1097\/PRS.0b013e31829ad411","article-title":"Managing malignant melanoma","volume":"132","author":"Dzwierzynski","year":"2013","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.bbrc.2018.06.010_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1634\/theoncologist.2010-0190","article-title":"Systematic review of medical treatment in melanoma: current status and future prospects","volume":"16","author":"Garbe","year":"2011","journal-title":"Oncol."},{"key":"10.1016\/j.bbrc.2018.06.010_bib3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/bmb\/ldu019","article-title":"Management of melanoma","volume":"111","author":"Corrie","year":"2014","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.bbrc.2018.06.010_bib4","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1158\/1078-0432.CCR-15-0732","article-title":"A\u00a0novel bioavailable BH3 mimetic efficiently inhibits colon cancer via cascade effects of mitochondria","volume":"22","author":"Wang","year":"2016","journal-title":"Clin. Canc. Res.: An Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/j.bbrc.2018.06.010_bib5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.canlet.2013.01.010","article-title":"Anti-apoptotic proteins on guard of melanoma cell survival","volume":"331","author":"Hartman","year":"2013","journal-title":"Canc. Lett."},{"key":"10.1016\/j.bbrc.2018.06.010_bib6","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1158\/0008-5472.CAN-14-3621","article-title":"Hyperthermia sensitizes glioma stem-like cells to radiation by inhibiting AKT signaling","volume":"75","author":"Man","year":"2015","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2018.06.010_bib7","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1158\/0008-5472.CAN-15-2908","article-title":"Hyperthermia synergizes with chemotherapy by inhibiting PARP1-dependent DNA replication arrest","volume":"76","author":"Schaaf","year":"2016","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2018.06.010_bib8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1080\/02656730802104740","article-title":"Fever-range whole-body thermal therapy combined with cisplatin, gemcitabine, and daily interferon-alpha: a description of a phase I-II protocol","volume":"24","author":"Bull","year":"2008","journal-title":"Int. J. Hyperther.: The Official Journal of European Society for Hyperthermic Oncology"},{"key":"10.1016\/j.bbrc.2018.06.010_bib9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1470-2045(02)00818-5","article-title":"Hyperthermia in combined treatment of cancer","volume":"3","author":"Wust","year":"2002","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbrc.2018.06.010_bib10","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3892\/ol.2012.804","article-title":"Antitumor effect and immune response induced by local hyperthermia in B16 murine melanoma: effect of thermal dose","volume":"4","author":"Li","year":"2012","journal-title":"Oncology letters"},{"key":"10.1016\/j.bbrc.2018.06.010_bib11","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1016\/j.febslet.2015.09.022","article-title":"Emerging targets for combination therapy in melanomas","volume":"589","author":"Saito Rde","year":"2015","journal-title":"FEBS Letters"},{"key":"10.1016\/j.bbrc.2018.06.010_bib12","doi-asserted-by":"crossref","first-page":"13547","DOI":"10.1038\/srep13547","article-title":"NF-kappaB signaling is essential for resistance to heat stress-induced early stage apoptosis in human umbilical vein endothelial cells","volume":"5","author":"Liu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2018.06.010_bib13","doi-asserted-by":"crossref","first-page":"7051","DOI":"10.18632\/oncotarget.2251","article-title":"Critical role of STAT3 in melanoma metastasis through anoikis resistance","volume":"5","author":"Fofaria","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2018.06.010_bib14","doi-asserted-by":"crossref","first-page":"7244","DOI":"10.1021\/acs.jmedchem.7b00228","article-title":"Blockade of asparagine endopeptidase inhibits cancer metastasis","volume":"60","author":"Qi","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.bbrc.2018.06.010_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF02071525","article-title":"Isolated limb perfusion for melanoma: effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs","volume":"16","author":"Thompson","year":"1992","journal-title":"World Journal of Surgery"},{"key":"10.1016\/j.bbrc.2018.06.010_bib16","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1517\/17425255.2010.503703","article-title":"Isolated limb infusion with melphalan and actinomycin D in melanoma patients: factors predictive of acute regional toxicity","volume":"6","author":"Kam","year":"2010","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.bbrc.2018.06.010_bib17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ncb2168","article-title":"Inactivation of Rheb by PRAK-mediated phosphorylation is essential for energy-depletion-induced suppression of mTORC1","volume":"13","author":"Zheng","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2018.06.010_bib18","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.3892\/mmr.2016.4838","article-title":"Prognostic value of legumain in uveal melanoma","volume":"13","author":"Wu","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbrc.2018.06.010_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2407-10-17","article-title":"Cystatin E\/M suppresses legumain activity and invasion of human melanoma","volume":"10","author":"Briggs","year":"2010","journal-title":"BMC Cancer"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18313226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18313226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T19:31:22Z","timestamp":1604431882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X18313226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0006291X18313226"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.06.010","relation":{},"ISSN":["0006-291X"],"issn-type":[{"type":"print","value":"0006-291X"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination therapy with BH3 mimetic and hyperthermia tends to be more effective on anti-melanoma treatment","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}